Afficher la notice abrégée

dc.contributor.authorHasan, Md. Mehdi
dc.contributor.authorMoniruzzaman, Md.
dc.contributor.authorAnee, Mubashwera
dc.contributor.authorRahaman, Md.Saydur
dc.contributor.authorRabbani, Golam
dc.contributor.authorBanik, Kallol
dc.contributor.authorRashid, Harun Ar
dc.date.accessioned2017-06-13T08:32:50Z
dc.date.available2017-06-13T08:32:50Z
dc.date.issued2017
dc.identifier.citationHasan, Md. Mehdi; Moniruzzaman, Md.; Anee, Mubashwera; Rahaman, Md.Saydur; Rabbani, Golam; Banik, Kallol & Rashid, Harun Ar (2017). Compensatory strategy on ocular drug delivery system, International Journal of Innovative Drug Discovery. 7(1),5-11.en_US
dc.identifier.issn2249 - 7609 (eISSN)
dc.identifier.issn2249 - 7617 (Print ISSN)
dc.identifier.urihttp://hdl.handle.net/123456789/1036
dc.description.abstractOcular anatomy and physiology is very unique which is why it creates a challenge in developing drugs given by ocular routes. The Eye has several layers of tissues in it. This route is extremely effective due to its rapid onset of action and small dose requirement. Transcorneal penetration is the route of absorption ofdrug.Several different dosage forms are being developed e.g nanoparticles, liposomes, nanomicelles and microemulsion to overcome difficul ties in drug delivery by this route. This review focused on ocular drug delivery has become the standard in modern pharmaceutical design and several possible routes of drug delivery into the ocular tissuesen_US
dc.language.isoenen_US
dc.publisherInternational Journal of Innovative Drug Discoveryen_US
dc.subjectOphthalmic drug delivery, Novel drug delivery, Occusert, Eye, gel.en_US
dc.titleCompensatory strategy on ocular drug delivery systemen_US
dc.typeArticleen_US


Fichier(s) constituant ce document

Thumbnail

Ce document figure dans la(les) collection(s) suivante(s)

Afficher la notice abrégée